Hematology NewsVenetoclax shows promise for r/r hairy cell leukemiaMarch 10, 2023Mixed TopicsCLLAMLCellular Therapy
Hematology NewsCLL treatment: More infections among real-world patientsMarch 6, 2023CLLB Cell Lymphoma
Hematology NewsHigh cost and demand for old cancer drug sparks crisisDecember 5, 2022CLLCellular TherapyMantle Cell Lymphoma
Hematology NewsFDA approved acalabrutinib tablet for MCL, CLL, SLLOctober 19, 2022Mantle Cell LymphomaCLL
Hematology NewsCAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Cellular TherapyAggressive LymphomasALLB Cell LymphomaMultiple MyelomaMixed TopicsCLL
Hematology NewsFirst drug therapy approved for childhood GVHDAugust 26, 2022ALLAMLMixed TopicsPediatricsCLLMantle Cell LymphomaTransplant
Hematology NewsYoung children with leukemia are outliving teensAugust 24, 2022PediatricsALLLeukemia, Myelodysplasia, TransplantationCLL
Hematology NewsWhere women’s voices still get heard lessAugust 18, 2022Diversity in MedicineMixed TopicsTranslational ResearchCLL
Hematology NewsPhase 3 data: Zanubrutinib bests standard CLL treatmentAugust 16, 2022CLLMantle Cell LymphomaB Cell Lymphoma
